中国麻风皮肤病杂志 ›› 2025, Vol. 41 ›› Issue (12): 902-906.doi: 10.12144/zgmfskin202512902

• 病例报告 • 上一篇    下一篇

托法替布联合阿维A治疗毛发红糠疹一例

毛海闵,诸曦,李卉,郭泽,王培光   

  1. 安徽医科大学第一附属医院,安徽合肥,230022
  • 出版日期:2025-12-15 发布日期:2025-11-28

Successful treatment of pityriasis rubra pilaris with tofacitinib and acitretin: a case report

MAO Haimin, ZHU Xi, LI Hui, GUO Ze, WANG Peiguang   

  1. The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China
  • Online:2025-12-15 Published:2025-11-28

摘要: 患者,男,63岁,全身红斑脱屑2个月,加重1个月。皮肤科查体:全身泛发红斑、鳞屑,躯干多处片状群集毛囊角化性丘疹。组织病理提示毛发红糠疹。予以阿维A口服联合司库奇尤单抗皮下注射治疗5周,全身皮损未有好转。改为托法替布联合阿维A口服治疗2周后开始好转,4周后显著好转。随访8个月,托法替布和阿维A减量后皮损轻度复发。

关键词: 毛发红糠疹, 托法替布, 阿维A

Abstract: A 63-year-old male presented with generalized erythema and desquamation for 2 months. Physical examination showed widespread erythema and scales on his whole body, with multiple grouped follicular keratotic papules on his trunk. The histopathological features of the skin lesion were consistent with those of pityriasis rubra pilaris. The patient was initially treated with oral acitretin combined with subcutaneous injections of secukinumab for 5 weeks, however, the disease was not improved. So, a combined treatment of oral tofacitinib and acitretin was used. After 4 weeks, a significant improvement was observed. There was mild recurrence of skin lesions after the dosage reduction of tofacitinib and acitretin at the 8-month follow-up.

Key words: pityriasis rubra pilaris, tofacitinib, acitretin